Generic Savings Vs. Patent Deadlines: A Reader Poll
23 CommentsBy Ed Silverman // October 26th, 2009 // 7:51 am
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Jan | Nov » | |||||
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
• Pharma Blog » 2009
Pharmalot October, 2009 Archive
NAMI: AstraZeneca Is A ‘Strong, Effective Partner’
10 CommentsBy Ed Silverman // October 26th, 2009 // 7:24 am
FDA Fails To Follow-Up On Questionable Drugs
5 CommentsBy Ed Silverman // October 26th, 2009 // 7:24 am
For AstraZeneca, Making Drugs Is Like Making Cars
3 CommentsBy Ed Silverman // October 26th, 2009 // 7:24 am
Europe Reviews Tysabri Over Brain Infections
4 CommentsBy Ed Silverman // October 26th, 2009 // 7:21 am
Canadian Judge: Zyprexa Is An ‘Almost Invention’
10 CommentsBy Ed Silverman // October 23rd, 2009 // 7:34 am
NAMI Board Member Consulted For AstraZeneca
7 CommentsBy Ed Silverman // October 23rd, 2009 // 6:51 am
Dartmouth: Lilly Payments Didn’t Violate Policy
1 CommentBy Ed Silverman // October 23rd, 2009 // 6:51 am